Announcement PDF Form 604 Corporations Act 2001 Section 671B Notice of Change of Interests of Substantial Holder To: RECCE PHARMACEUTICALS LTD ACN/ARSN: 1. Details of substantial holder (1) Name: FIL Limited and its entities listed in Annexure A ("FIL") ACN/ARSN (if applicable) There was a change in the interests of the substantial holder on 03 June 2025 The date of awareness of change in the interests of the substantial holder on 10 June 2025 The previous notice was given to the company on 20 May 2025 The previous notice was dated 20 May 2025 2. Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows: Class of Securities (4) COMMON STOCK Previous Notice Person’s votes 16,755,072 Previous Notice Voting Power (5) 6.40% Present Notice Person’s votes 24,705,816 Present Notice Voting Power (5) 8.57% 3. Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of Change Person whose relevant interest changed 06/03/2025 Nature of change (6) FIL BUY Consideration given in relation to change (7) 0.2800 AUD Class and number of securities affected COMMON STOCK 7,950,744 Person’s votes affected COMMON STOCK 7,950,744 4. Present Relevant Interest Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows: Refer to Annexure A 5. Changes in Association The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows: Name and ACN/ARSN (if applicable) N/A Nature of association 6. Addresses The addresses of persons named in this form are as follows: The address of FIL Limited is Pembroke Hall, 42 Crow Lane, Pembroke, HM 19, Bermuda and please refer to Annexure A for its entity with relevant interest Sign Here _____________________________ Dated: 12 June 2025 Alina Yu Regulatory Reporting Manager Duly authorized under Powers of Attorney by and on behalf of FIL Limited Annexure A Investment Manager Address Custodian FIL Investment Management (Hong Kong) Limited Level 21, Two Pacific Place, 88 Queensway, Admiralty, Hong Kong BROWN BROS HARRIMN LTD LUX (C) CLEARSTREAM BANKING SA LUX (C) LANDESBANK BADEN-WUERTTEMBERG Grand Total Nature of Relevant Interest Sum of Numerator Shares 15,986,615 Investment Discretion / Voting Power 5,306,550 3,412,651 24,705,816